Wires·
Standing by — next sweep in ~7 min.
Markets
Dow+0.77%Russell 2000-0.42%Nasdaq+2.37%S&P 500+1.60%VXX-4.29%IEF+0.00%GLD-1.37%SLV-1.15%USO+1.28%UUP-0.28%Dow+0.77%Russell 2000-0.42%Nasdaq+2.37%S&P 500+1.60%VXX-4.29%IEF+0.00%GLD-1.37%SLV-1.15%USO+1.28%UUP-0.28%

The Daily Digest

A one-read trader's notebook on what the agents did today and what it teaches us. Sent each weekday after the US market close.

One paragraph, sent each weekday after the close. Free. Unsubscribe link in every email.

The Ledger · Daily Digest

Sunday, June 28, 2026

Combined portfolio
$2,021,891
+$20,891 (+1.04%) vs. start of test
A note from the founder

Weekend Reading

Saturday/Sunday issue. News from the past five days, tied to the names the agents are currently holding.

COP, CVX, XOMUS-Iran military exchange escalates with Hormuz shipping at risk

The US military struck Iranian targets following a tanker incident in the Strait of Hormuz, and Iran's Revolutionary Guards reported retaliatory strikes on US-linked regional positions. The exchange marks the most direct US-Iran military confrontation in years. The Strait of Hormuz carries roughly 20% of global oil trade, so any sustained disruption would be a hard supply shock.

*Impact:* Oil-price spike risk is the immediate read-through — energy sector gets a bid, but broader equities face a stagflationary headwind; the agents' energy puts (SLB, HAL, OXY, DVN) and longs (EQT, FANG) are sitting in the middle of this cross-current, and macro-sensitive positions across industrials and financials face added uncertainty.

MSFT, GOOG, GOOGL, META, AMZNTrump threatens 100% tariffs on EU digital services tax countries

The Trump administration signaled it would impose 100% tariffs on European nations that levy digital services taxes targeting US tech firms. The EU has been moving to designate Amazon and Microsoft cloud units as 'gatekeepers' under its Digital Markets Act the same week, compounding the friction. A 100% tariff threat is more of a negotiating posture than an overnight policy, but it adds a real compliance and revenue-risk overlay for the hyperscalers doing meaningful European business.

*Impact:* All five names above are held by agents and already carry EU regulatory exposure — the DMA gatekeeper designation for MSFT and AMZN landed this week on top of the tariff threat, making the European regulatory overhang a live issue for dip_buyer and immutable positions in those names.

Asian equities tumble as OpenAI IPO delay rattles AI sentiment

Seoul's KOSPI dropped roughly 8% amid reports that OpenAI's IPO timeline was being pushed back, triggering a broad sell-off in AI-leveraged equities across Asian markets. The reaction reflects how tightly crowded the global AI trade has become — any signal that the monetization event for the sector's flagship private company is further out compounds the valuation pressure that was already building from elevated capex spending and debt issuance headlines.

*Impact:* The ripple landed on the Nasdaq 100, which fell 4.6% on the week — directly pressuring the agents' tech-heavy longs in NVDA, GOOGL, MSFT, AVGO, MRVL, and the sector_long XLK position, while providing a tailwind for inverse holdings like PSQ and SQQQ.

Fed Chair Warsh signals policy shift that could tighten financial conditions

New Federal Reserve Chairman Kevin Warsh used his first press conference to flag structural concerns about financial markets and outline potential policy changes. Warsh, a known hawk who has historically favored tighter money and balance sheet normalization, replacing a more dovish predecessor matters for rate-sensitive assets. The details remain vague but the directional signal — less accommodation, potentially earlier — is clear enough to move bond proxies and rate-sensitive equities.

*Impact:* This is a direct headwind for the agents' significant utility longs (DUK, XEL, AEP, LNT, PNW, WEC, CMS), REIT positions (O, MAA, FRT, REG), and the dip_buyer MSFT and AMZN longs, all of which were entered partly on a 'rates-plateauing' assumption.

AVGOBroadcom and OpenAI ship Jalapeño inference chip in nine months

OpenAI and Broadcom announced the commercial launch of Jalapeño, a custom AI inference chip optimized for large language model workloads. The chip reached tape-out in roughly nine months, an unusually fast hardware development cycle. It is the first product in a planned multi-generation AI compute platform, positioning Broadcom as OpenAI's silicon partner of record on the inference side.

*Impact:* This is substantive product news, not a press release — it validates Broadcom's custom ASIC strategy and adds a flagship customer anchor to the revenue story; both dip_buyer_frozen and dip_buyer_peer_aware agents entered AVGO well below current prices with a $495 target, and the Jalapeño announcement is the kind of design-win confirmation that supports that thesis.

MRVLMarvell guides FY27 revenue to $11.5B with interconnect growth over 70%

Marvell Technology raised its FY27 revenue guidance to approximately $11.5 billion and lifted its interconnect growth forecast from 50% to over 70% year-over-year, driven by AI data center demand for its custom silicon and networking products. Stifel followed by raising its price target to $350 from $321, maintaining a Buy rating.

*Impact:* The dip_buyer_frozen agent holds MRVL from $266.88 with a $324.20 target — the guidance raise puts meaningful upside on the table and the stock at $266 is now pricing in a fraction of the revised growth trajectory, making the position look well-supported on fundamentals.

MSMorgan Stanley raises MS dividend to $1.15 and reauthorizes $20B buyback

Morgan Stanley announced a 15% increase in its quarterly common stock dividend to $1.15 per share and reauthorized a multi-year share repurchase program of up to $20 billion. The move follows post-stress-test capital clarity and signals management confidence in earnings durability. The buyback authorization is notably open-ended rather than time-limited.

*Impact:* Both the fifty_two_week_high and sir_pv agents hold MS near current levels — the buyback and dividend hike are exactly the capital-return signals those methodologies weight, and the $20B authorization at a ~$180B market cap is 11% of float, which is a meaningful floor for the stock.

GOOG, GOOGL, METAGoogle's Gemini capacity crunch disrupts Meta's AI development

The Financial Times reported that Google told Meta around March it could not supply the full Gemini compute capacity Meta had sought to purchase, delaying some of Meta's internal AI projects. The shortfall also affected other Google cloud clients. The story cuts two ways: it reveals execution risk in Google's cloud scaling, but also confirms demand for Gemini is outrunning supply — which is typically a pricing and margin positive.

*Impact:* For the Alphabet positions (multiple dip_buyer and immutable agents holding GOOG/GOOGL underwater from $348–$389), the capacity constraint framing is more bullish than bearish — supply-constrained AI infrastructure is a revenue story; for the adaptive and immutable short agents holding META at $598.71 with the stock near $550, the AI development delay adds a modest fundamental wrinkle to an already profitable short.

ABBVAbbVie acquires Apogee Therapeutics to expand immunology pipeline

AbbVie announced a definitive agreement to acquire Apogee Therapeutics, which holds a diverse set of clinical-stage candidates in immunological and inflammatory diseases. The deal adds pipeline depth at a point when AbbVie is managing the long tail of Humira biosimilar competition. The same week, Health Canada approved Boey (botulinum toxin) for the aesthetics division, adding a small but de-risked revenue stream.

*Impact:* The sir_pv agent entered ABBV at $229.96 targeting $275.95 — pipeline acquisitions in immunology are core to AbbVie's post-Humira reinvention narrative, and this deal directly addresses the growth-gap concern that has kept a ceiling on the stock.

GILDGilead wins FDA approval for Trodelvy in first-line triple-negative breast cancer

The FDA approved Trodelvy (sacituzumab govitecan) for two indications in adults with triple-negative breast cancer, including a first-line approval. TNBC is a high-unmet-need market with limited treatment options; moving into first-line significantly expands the addressable patient population compared to the prior later-line label.

*Impact:* The dip_buyer_frozen agent entered GILD at $123.69 targeting $137.50, and a label expansion of this magnitude — first-line TNBC is a meaningful commercial step-up — is a genuine revenue catalyst, not just regulatory noise.

TSLATesla plans 20% Berlin production increase to 7,500 vehicles per week

Tesla announced it will raise production at its Gigafactory Berlin by 20%, targeting 7,500 vehicles per week from October. The ramp adds roughly 100,000 units of annual European capacity. Separately, Tesla completed a key AI chip milestone tied to its robotics and non-automotive AI push.

*Impact:* The dip_buyer_frozen agent holds TSLA from $381.59 targeting $453.40 — operational execution in Europe has been a persistent concern, and a concrete production ramp with a timeline is incrementally supportive, though the stock remains below entry and the position needs broader risk-on sentiment to close the gap.

WRBW.R. Berkley announces special dividend, buyback reset, and AM Best upgrade

W.R. Berkley declared a $0.50 special cash dividend, raised its regular quarterly dividend by 11.1% to $0.10, restored its share repurchase authorization to 25 million shares, and received an AM Best Long-Term Issuer Rating upgrade to 'a' (Excellent). The cluster of actions in a single month is unusually active capital return signaling for a specialty insurer.

*Impact:* The options_momentum agent bought WRB $71 calls expiring July 31 just two days before these announcements — the stock was already up 6.1% on the week, and the position at $2.04 entry now has a meaningful catalyst-driven tailwind heading into expiry.

AAPLApple raises Mac and iPad prices in a break from its long-standing practice

Apple confirmed price increases on Macs and iPads, an unusual move for a company that has historically absorbed component cost increases rather than passing them to consumers. The increases are attributed to tariff pressure. KGI Securities downgraded AAPL to Hold with a $315 target the same week, citing the price increase risk to demand elasticity.

*Impact:* The immutable agent holds 34 shares of AAPL from $292.75 — the stock is already below entry at $283.78, and price increases that risk unit demand in a consumer that is already showing savings stress (May data flagged this week) are a legitimate headwind to the bull case, not just analyst noise.

NUE, STLDNUE upgraded to Overweight at KeyBanc after pullback; STLD guides Q2 EPS below estimates

KeyBanc upgraded Nucor to Overweight from Sector Weight with a $274 target, expecting US carbon steel demand to grow 2% year-over-year in 2026. Across town, Steel Dynamics issued Q2 EPS guidance of $3.51–$3.55, below prior analyst estimates, citing margin pressure. The divergence between the two names — both held by agents — reflects real operating differences rather than a sector-wide story.

*Impact:* Both the fifty_two_week_high and sir_pv agents hold NUE from ~$251 with the stock at $239 — a KeyBanc upgrade with a $274 target is directionally helpful but doesn't change the fact that both positions are offside; STLD guidance miss puts the fifty_two_week_high STLD long further underwater and warrants watching against its entry of $261.

USB, TFCUS bancorp stress capital buffer unchanged; stable dividend and healthcare payments push

U.S. Bancorp reported that the Fed's stress capital buffer requirement was unchanged through 2027, affirmed its $0.52 quarterly dividend, and announced new leadership in healthcare payments — a higher-margin, less-cyclical revenue stream it is actively building out. Separately, Stephens resumed coverage of Truist with an Overweight rating and a $59 target, calling it broadly constructive on super-regional banks.

*Impact:* The options_momentum agent holds USB $61 calls expiring July 31 from $2.19 — stable capital buffers post-stress-test and a dividend reaffirmation remove a near-term overhang, modestly supportive for a call position that needs the stock to move; TFC's call position (strike $51, exp July 31) benefits from the same post-stress-test clarity that Stephens cited in resuming coverage.

Paper trades only · Not investment advice

One email per weekday. Unsubscribe link in every send. Your email is used only to send you this digest and is not shared with anyone.

No real money. No broker connection. Just a 365-day research log made public.